...
机译:乳头状甲状腺癌BRAFV600E sup>突变与已建立的预后因素的关系
Department of Pathology, Gülhane Military Medical Academy and School of Medicine, 06018, Etlik, Ankara, Turkey;
Kaman Vocational School, Ahi Evran University, Kırıkkale, Turkey;
Department of Nuclear Medicine, Gülhane Military Medical Academy and School of Medicine, 06018, Etlik, Ankara, Turkey;
Department of Pathology, Gülhane Military Medical Academy and School of Medicine, 06018, Etlik, Ankara, Turkey;
Department of Pathology, Gülhane Military Medical Academy and School of Medicine, 06018, Etlik, Ankara, Turkey;
Department of Pathology, Gülhane Military Medical Academy and School of Medicine, 06018, Etlik, Ankara, Turkey;
Department of Pathology, Gülhane Military Medical Academy and School of Medicine, 06018, Etlik, Ankara, Turkey;
Papillary thyroid carcinoma; BRAFV600E; Prognosis; Diagnosis;
机译:甲状腺乳头状癌BRAF V600E突变与已建立的预后因素的关系
机译:细针抽吸术中存在BRAFV600E突变:与较大的甲状腺乳头状癌的不良预后相关
机译:Brafv600E突变是一种独立的,预后的预后因素,患有低风险肺结泡乳头状甲状腺癌的患者的结果:单机制由大型队列研究产生
机译:形态计量学对甲状腺乳头状癌的预后价值
机译:甲状腺乳头状癌的免疫浸润。
机译:乳头状甲状腺癌的临床病理特征和预后及其与BRAFV600E突变状态和血管生成因子表达的关系
机译:甲状腺乳头状微小癌手术的临床病理特征和预后及与BRaFV600E突变状态及血管生成因子表达的关系。